United Therapeutics (UTHR) Equity Income (2009 - 2013)
United Therapeutics (UTHR) posted Equity Income of -$72,000 for Q2 2013, compared with -$42,000 a year earlier.
Powered by 
Analysis
United Therapeutics (UTHR) Equity Income (2009 - 2013) Analysis & Trends
For the trailing twelve months through Jun 30, 2013, Equity Income at United Therapeutics was -$200,000; for FY2012, it came in at -$143,000.
- In prior years, United Therapeutics' Equity Income was -$119,000 in FY2011, -$160,000 in FY2010 and -$141,000 in FY2009.
- The Q2 2013 figure stands as the lowest quarterly Equity Income in data going back to Q2 2009.
- According to Business Quant data, Equity Income for the three prior quarters was -$47,000 (Q1 2013), -$33,000 (Q4 2012) and -$48,000 (Q3 2012).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | - |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | United Therapeutics | 25.03 Bn | 15.22 Bn | 733.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2013 | -72,000.00 |
| Mar 31, 2013 | -47,000.00 |
| Dec 31, 2012 | -33,000.00 |
| Sep 30, 2012 | -48,000.00 |
| Jun 30, 2012 | -42,000.00 |
| Mar 31, 2012 | -20,000.00 |
| Dec 31, 2011 | -9,000.00 |
| Sep 30, 2011 | -43,000.00 |
| Jun 30, 2011 | -30,000.00 |
| Mar 31, 2011 | -37,000.00 |
| Dec 31, 2010 | -30,000.00 |
| Sep 30, 2010 | -39,000.00 |
| Jun 30, 2010 | -44,000.00 |
| Mar 31, 2010 | -47,000.00 |
| Dec 31, 2009 | -42,000.00 |
| Sep 30, 2009 | -42,000.00 |
| Jun 30, 2009 | -38,000.00 |
API Access
United Therapeutics Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();